IRVINE, CA, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Signature Devices, Inc. (OTC PINK: SDVI), and its subsidiary Nano 101, today announced the expansion of its existing cannabidiol (CBD) and hemp product lines by the end of Q4 2019.
Founded in 2017, Nano 101 is a nutraceutical technology company with a focus on hemp and CBD (cannabidiol) products. Nano 101 has been at the forefront of developing the latest hemp based topical delivery systems the culmination of which has been its flagship 120 mg CBD patch, which is the highest dosage CBD topical patch available on the market. The company also has a 75mg Pure Hemp Patch which is a hemp oil patch rich in phytocannabinoids and terpenes.
Up till December of 2018, the question of whether CBD was federally legal had been vague and up in the air. Even though most states had legalized cannabidiol, ambiguity at the federal level was a cause of worry for many retailers and consumers of CBD.
The 2018 Farm Bill finally puts the CBD legality question to rest. The bill makes hemp legal in all 50 states and the plant is now an agricultural commodity. Industrial hemp and its derivatives, such as CBD oil, are now not part of the controlled substances act.
“While we never had any issues, a large portion of our customers expressed concern about purchasing and using hemp, especially, CBD-based products. Passage of the bill goes a long way to easing the minds of these customers,” says Mr. Ray Khan, CEO of Nano 101.
“The bill also opens up the door for us to diversify our product lines,” continues Mr. Ray Khan, CEO of Nano 101.
Indeed, Nano 101 has announced it will diversify its topical product line up. The company plans on developing a variety of patch systems that will have varying dosages of CBD oil infused in them. The primary focus will be on larger and higher dose CBD patches for those looking for something even stronger. In addition to different dosages, Nano 101 will offer patches with new CBD formulations to address different issues such as joint pain, inflammation, anxiety, and insomnia.
In addition to topical systems Nano 101 has also announced plans to enter the traditional oral CBD/Hemp space with the introduction of different CBD-based edibles and drinks by Q1 2020. Nano 101 plans to include products such as CBD gummies, K-cups, gel shots, and beverages in its lineup in the near future.
“While our primary focus has been the development of topical CBD patches, we now feel comfortable to introduce an innovative array of new products to the market by early 2020. With the Farm Bill passed, the sky is truly the limit for us when it comes to CBD,” says Mr. Ray Khan, CEO of Nano 101.
The 120mg CBD patch is available in 3 different quantities of patches (6, 18, 30). More information can be found at the Nano CBD Plus website:
The 75mg Pure Hemp Patch is also available in 3 different quantities (6, 18, 30). More information can be found here:
You can also follow the company on Twitter for small updates and announcements,
https://twitter.com/SignatureDevice
About Nano 101
Based in Irvine, California, Nano 10, Inc. (www.nano101.io) was founded by a diverse set of individuals, including physicians, clinical researchers, naturopaths and botanists, who all have had a strong history and interest in hemp-based therapeutics. The goal of the company has been to combine the latest hemp-based therapeutics with the latest topical delivery systems.
About Signature Devices, Inc.
Based in Sheridan, Wyoming, Signature Devices, Inc. (www.signaturedevices.com) (OTC PINK: SDVI) is a holding company with various subsidiaries that develop Internet of Things (IOT) products through its subsidiary Innovo Technologies, Inc., and publishes diverse media products including video games and mobile applications through its subsidiary Graffiti Entertainment, Inc.
Forward-Looking Statements:
The information in this press release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.